Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 May 15;21(10):3490.
doi: 10.3390/ijms21103490.

Methylmercury Poisoning Induces Cardiac Electrical Remodeling and Increases Arrhythmia Susceptibility and Mortality

Affiliations

Methylmercury Poisoning Induces Cardiac Electrical Remodeling and Increases Arrhythmia Susceptibility and Mortality

Mara Cristina P Santos Ruybal et al. Int J Mol Sci. .

Abstract

This study aims to investigate the cardiac electrical remodeling associated with intoxication by methylmercury (MeHg). We evaluated the chronic effects of MeHg on in vivo electrocardiograms and on ex vivo action potentials and depolarizing (ICa-L) and repolarizing (Ito) currents. The acute effect of MeHg was evaluated on HEK293 cells expressing human ERG, Kv4.3 and KCNQ1/KCNE1 channels. Chronic MeHg treatment increased QTc and Tpeak-Tend interval duration, prolonged action potential duration and decreased amplitude of Ito and ICa-L. In addition, heterologously expressed IhKv4.3, IhERG or IhKCNQ1/KCNE1 decreased after acute exposure to MeHg at subnanomolar range. The introduction of the in vitro effects of MeHg in a computer model of human ventricular action potentials triggered early afterdepolarizations and arrhythmia. In conclusion, cardiac electrical remodeling induced by MeHg poisoning is related to the reduction of Ito and ICa-L. The acute effect of MeHg on hKv4.3; hERG and hKCNQ1/KCNE1 currents and their transposition to in silico models show an association between MeHg intoxication and acquired Long QT Syndrome in humans. MeHg can exert its high toxicity either after chronic or acute exposure to concentrations as low as picomolar.

Keywords: arrhythmia; cardiac; electrical remodeling; ion current; mercury.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses or interpretation of data; in the writing of the manuscript or in the decision to publish the results.

Figures

Figure 1
Figure 1
Chronic MeHg treatment prolongs cardiac repolarization in vivo. (A) Electrocardiograms of a conscious animal before and 4 weeks after treatment with MeHg 3 mg/kg·day (dashed lines show the QT interval). RR interval (B), QT interval, (C) heart rate corrected QT interval, QTc, (D) and repolarization dispersion, Tpeak–Tend (E) were prolonged after MeHg treatment. n = 13 control and 15 MeHg-treated animals. * p < 0.05; ** p < 0.01.
Figure 2
Figure 2
MeHg prolongs ventricular action potential duration. (A) ventricular action potentials were recorded in epicardial strips from control and MeHg-treated animals; (B) action potential duration at 90% of repolarization (APD90) and (C) action potential (AP) triangulation at different basic cycle length (BCL), in control (open symbols) or after 4 weeks of treatment with MeHg (filled symbols). * p < 0.05. n = 7 control and 14 MeHg-treated hearts per group.
Figure 3
Figure 3
MeHg treatment reduces the transient outward K+ and the L-type Ca2+ currents in ventricular myocytes. (A) ICa-L currents were recorded at voltages from −50 to +60 mV in ventricular myocytes isolated from animals after 4 weeks in control conditions or treated with MeHg. Current–voltage relationship obtained in myocytes from animals treated with vehicle (open symbols, n = 7) or with MeHg (filled symbols, n = 6). (B) Ito traces recorded at potentials between −50 and +60 mV in ventricular myocytes isolated from animals after 4 weeks in control conditions or treated with MeHg. Current–voltage relationship obtained in myocytes from animals treated with vehicle (open symbols, n = 18) or with MeHg (filled symbols, n = 14). ** p < 0.01.
Figure 4
Figure 4
MeHg reduces repolarization capability in human cells in vitro. Representative traces and average current density-voltage relationships obtained in HEK293 cells expressing (A) Kv4.3 channels, (B) hERG channels, or (C) Kv7.1/KCNE1 channels. MeHg acute exposure reduces all currents in a concentration dependent manner. n = 8–15 cells. * p < 0.05; ** p < 0.01.
Figure 5
Figure 5
Modeling the effects of acute MeHg-induced changes in ion currents on human ventricular action potential. Computational models were generated to simulate action potential of 100 control individuals in resting conditions and under β-adrenergic stimulation. For clarity, only the first 15 traces are shown. When the ionic conductances were changed to simulate the effects of 0.01 nM MeHg AP duration increases in resting conditions, but after β-adrenergic stimulation, 33% of action potentials generated early afterdepolarizations and arrhythmia. When the ionic conductances were changed to simulate the effects of 0.1 nM MeHg 98% models showed early afterdepolarizations (EADs) and arrhythmia in resting conditions and 100% after β-adrenergic stimulation.

Similar articles

Cited by

References

    1. Wolf M.B., Baynes J.W. Cadmium and mercury cause an oxidative stress-induced endotelial dysfunction. BioMetals. 2007;20:73–81. doi: 10.1007/s10534-006-9016-0. - DOI - PubMed
    1. Zukowska J., Biziuk M. Methodological evaluation of method for dietary heavy metal intake. J. Food Sci. 2008;73:R21–R29. doi: 10.1111/j.1750-3841.2007.00648.x. - DOI - PubMed
    1. Singh R., Gautam N., Mishra A. Heavy metals and living systems: An overview. Indian J. Pharmacol. 2011;43:246–253. doi: 10.4103/0253-7613.81505. - DOI - PMC - PubMed
    1. Clarkson T.W. The pharmacology of mercury compounds. Annu. Rev. Pharmacol. 1972;12:375–406. doi: 10.1146/annurev.pa.12.040172.002111. - DOI - PubMed
    1. Möller-Madsen B. Localization of mercury in CNS of the rat. Pharmacol. Toxicol. 1994;75:11–12. doi: 10.1111/j.1600-0773.1994.tb01927.x. - DOI - PubMed